Why FND Affects More Women: What MS Patients Should Know

Credibility

Interest

Key Takeaway

Functional neurological disorder (FND) affects about three times more women than men because both biological factors like sex hormones and social factors like trauma and inequality combine to raise risk.

What They Found

The study found that FND is much more common in women, about a 3 to 1 ratio, making it one of the most female-predominant brain–mind conditions reviewed. Researchers saw that hormones such as estrogen and progesterone can change how the brain reacts to stress and movement control, which may make some women more vulnerable. Life experiences that happen more often to women, like certain kinds of trauma or social disadvantage, also increase the chance of developing FND. The paper noticed that FND shares features with other conditions tied to stress, dissociation (a disconnection between thoughts, memories, or identity), and internal feelings like anxiety and depression. Overall, the authors suggest FND likely comes from a two-way interaction between body factors (hormones) and social experiences (stress, trauma, roles), not from one single cause.

Who Should Care and Why

People with MS and caregivers should care because FND can cause neurological symptoms that overlap with MS, like weakness, tremor, or problems walking, so understanding risk and causes helps with diagnosis and care. Caregivers and healthcare providers should know that symptoms may come from a mix of body and life experiences, not ‘all in the head,’ which can reduce blame and improve support. Knowing that hormones and stress may interact to cause symptoms can help when planning treatments that address both physical and emotional needs, much like treating both the engine and the road when a car drives poorly. Women with MS may be especially interested because the same gendered social pressures and hormonal effects discussed in the study can also affect MS symptom flares, mood, and stress coping. Clinicians who treat MS should consider screening for trauma, stress, and symptom patterns that might suggest co-existing FND so patients get the right therapies faster.

Important Considerations

This paper is a narrative review, which summarizes existing studies but does not prove cause and effect; it brings together ideas rather than reporting new experiments. Many studies discussed have limits: some use different ways to diagnose FND or measure trauma, and research often focuses more on women, which can affect conclusions. Because of these uncertainties, the findings should guide more careful, gender-aware care and more research, rather than be taken as a final answer.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Mental Wellness Early Research Specific Symptoms

Article Topics:

Genderfunctional neurological disordersneurological illnessespsychiatric illnesses

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Psychological medicine often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News